MedPath

Double Ligation and Topical Silver Nitrate

Phase 2
Completed
Conditions
Umbilical Granuloma
Interventions
Procedure: Double Ligation
Registration Number
NCT04248101
Lead Sponsor
Shaheed Zulfiqar Ali Bhutto Medical University
Brief Summary

To study and compare the efficacy and safety of Double Ligation and Topical Silver Nitrate Solution while treating children with Umbilical Granulomas

Detailed Description

The patients underwent one treatment option and then followed up for three weeks and the results noted in terms of success/failure and complications specific to each treatment option and analysed accordingly

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
176
Inclusion Criteria
  1. Patients of Umbilical Granuloma, less than 1 year age
Exclusion Criteria
  1. Patients who already had any treatment
  2. Parents refused to give consent for enrollment
  3. Patients lost in follow up

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 2Topical Silver Nitrate88 cases of umbilical granulomas who were treated with topical silver nitrate
Group 1Double Ligation88 cases of umbilical granulomas who were treated with double ligation
Primary Outcome Measures
NameTimeMethod
Frequency of Success/Failure of treatment3 weeks

The effect of treatment was noted in a structured proforma on weekly basis for 3 weeks.

Treatment was considered successful if, on local examination the granuloma disappeared completely and did not reappear during the follow up period.

And if the granuloma did not disppear completely during the follow up period after double ligation or application of silver nitrate, treatment was considered to have failed.

These variables were measured as frequency and percentages. The results were compared between the two groups using chi-square test. A significance level of \<0.05 was considered significant.

Frequency of complications in both groups3 weeks

The complications were also noted in the above mentioned proforma during the follow up period on weekly basis for 3 weeks.

Complications relevant to the treatment i.e. infection, bleeding, chemical burns and skin discoloration were noted during local examination.

These variables were measured as frequency and percentages. The results were compared between the two groups using chi-square test. A significance level of \<0.05 was considered significant

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath